Home
About
FAQ
History (25)
Phase I dose-escalation study to determine the safety, pharmacokinetics and pharmacodynamics of brivanib alaninate in combination with full-dose cetuximab in patients with advanced gastrointestinal malignancies who have failed prior therapy.
Databases, Bibliographic
Epitope Mapping
AC133, a novel marker for human hematopoietic stem and progenitor cells.
Mastectomy
See All 25 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Results (7)
More Search Options
Sort
Query Relevance
Name (A-Z)
Name (Z-A)
Institution (A-Z)
Institution (Z-A)
Show
(choose columns)
Faculty Rank
Name
Institution
Why
B. Scott Segal MD, MHCM
Wake Forest School of Medicine
Why?
Barry I. Freedman MD
Wake Forest School of Medicine
Why?
Anthony Atala MD
Wake Forest School of Medicine
Why?
Per Page
15
25
50
100
Page
of 1
Next
Prev
Search Criteria
Inhibin
beta
Subunits
Click "Why?" to see why a person matched the search.
Search Options
Modify Search
Search Other Institutions